{"id":"NCT00615459","sponsor":"Novartis","briefTitle":"A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control","officialTitle":"A Phase III, Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, 3-period Incomplete Block, Multidose Crossover Study to Determine the Effect on Lung Function of Indacaterol (150 and 300 μg o.d.) in Patients With Moderate to Severe COPD, Using Tiotropium (18 μg o.d.) as an Active Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2008-02-14","resultsPosted":"2011-08-17","lastUpdate":"2011-08-17"},"enrollment":169,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"Indacaterol","otherNames":[]},{"type":"DRUG","name":"Tiotropium","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sequence 1: Placebo,Tiotropium, Indacaterol 150 μg","type":"EXPERIMENTAL"},{"label":"Sequence 2: Indacaterol 300 μg, Indacaterol 150 μg, Tiotropium","type":"EXPERIMENTAL"},{"label":"Sequence 3: Indacaterol 150 μg, Indacaterol 300 μg, Placebo","type":"EXPERIMENTAL"},{"label":"Sequence 4: Tiotropium, Placebo, Indacaterol 300 μg","type":"EXPERIMENTAL"}],"summary":"The study compared the 24-hour spirometry profile of indacaterol with that of placebo and with tiotropium as an active control in patients with chronic obstructive pulmonary disease.","primaryOutcome":{"measure":"24-hour Post-dose Trough Forced Expiratory Volume in 1 Second (FEV1) After 14 Days of Treatment","timeFrame":"23 hours 10 minutes and 23 hours 45 minutes post-dose on Day 15 of each treatment period","effectByArm":[{"arm":"Indacaterol 150 μg","deltaMin":1.53,"sd":0.021},{"arm":"Indacaterol 300 μg","deltaMin":1.51,"sd":0.021},{"arm":"Tiotropium 18 μg","deltaMin":1.48,"sd":0.021},{"arm":"Placebo","deltaMin":1.36,"sd":0.021}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":11},"locations":{"siteCount":20,"countries":["Australia","Germany","Netherlands","New Zealand","Poland","South Africa","Spain"]},"refs":{"pmids":["20920365"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":118},"commonTop":["Nasopharyngitis","Chronic obstructive pulmonary disease","Cough"]}}